tiprankstipranks
Advertisement
Advertisement

BMRN Stock Latest News

BioMarin’s IMPALA Study Aims to Boost Palynziq Value With Better Tolerability
Company AnnouncementsBioMarin’s IMPALA Study Aims to Boost Palynziq Value With Better Tolerability
19d ago
BMRN
BioMarin’s Voxzogo and BMN 333 show impact in hypochondroplasia, achondroplasia
PremiumThe Fly
BioMarin’s Voxzogo and BMN 333 show impact in hypochondroplasia, achondroplasia
20d ago
BMRN
Ascendis Pharma ‘oversold’ following ITC development, says Oppenheimer
PremiumThe Fly
Ascendis Pharma ‘oversold’ following ITC development, says Oppenheimer
27d ago
ASND
BMRN
BioMarin Shareholders Approve 2026 Governance and Equity Plan
PremiumCompany Announcements
BioMarin Shareholders Approve 2026 Governance and Equity Plan
1M ago
8K
BMRN
Jason Gerberry Maintains Buy on BioMarin, Reiterates $80 Price Target Despite Voxzogo Patent Uncertainty
PremiumRatings
Jason Gerberry Maintains Buy on BioMarin, Reiterates $80 Price Target Despite Voxzogo Patent Uncertainty
1M ago
BMRN
3 Best Stocks to Buy This Week, According to Analysts – May 25-May 29
PremiumMarket News3 Best Stocks to Buy This Week, According to Analysts – May 25-May 29
1M ago
BMRN
FUTU
BioMarin price target lowered to $111 from $116 at Canaccord
Premium
The Fly
BioMarin price target lowered to $111 from $116 at Canaccord
2M ago
BMRN
Buy Rating Reaffirmed on BioMarin as Voxzogo Skeletal Disorder Opportunity Expands; $94 Price Target Maintained
Premium
Ratings
Buy Rating Reaffirmed on BioMarin as Voxzogo Skeletal Disorder Opportunity Expands; $94 Price Target Maintained
2M ago
BMRN
BioMarin’s Voxzogo meets endpoint in Phase 3 pediatric hypochondroplasia trial
PremiumThe Fly
BioMarin’s Voxzogo meets endpoint in Phase 3 pediatric hypochondroplasia trial
2M ago
BMRN
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
PremiumThe Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
2M ago
AMT
BAP
BioMarin price target lowered to $80 from $85 at BofA
PremiumThe Fly
BioMarin price target lowered to $80 from $85 at BofA
2M ago
BMRN
BioMarin initiated with a Buy at Citi
PremiumThe Fly
BioMarin initiated with a Buy at Citi
2M ago
BMRN
BioMarin price target lowered to $62 from $64 at Leerink
PremiumThe FlyBioMarin price target lowered to $62 from $64 at Leerink
2M ago
BMRN
BioMarin price target lowered to $50 from $55 at H.C. Wainwright
Premium
The Fly
BioMarin price target lowered to $50 from $55 at H.C. Wainwright
2M ago
BMRN
BioMarin’s BMN 401 meets 1 of 2 endpoints in Phase 3 ENPP1 trial
Premium
The Fly
BioMarin’s BMN 401 meets 1 of 2 endpoints in Phase 3 ENPP1 trial
2M ago
BMRN
Morgan Stanley Sees the S&P 500 Hitting 8,300 – 2 Stocks It Says Could Surge Alongside It
PremiumMarket News
Morgan Stanley Sees the S&P 500 Hitting 8,300 – 2 Stocks It Says Could Surge Alongside It
2M ago
ARXS
BMRN
BioMarin Extends BMN 351 Duchenne Study, Keeping Long-Term Data in Focus for Investors
PremiumCompany Announcements
BioMarin Extends BMN 351 Duchenne Study, Keeping Long-Term Data in Focus for Investors
2M ago
BMRN
Dell downgraded, Uber upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Dell downgraded, Uber upgraded: Wall Street’s top analyst calls
2M ago
CG
FTV
BioMarin reinstated with a Neutral at Goldman Sachs
PremiumThe Fly
BioMarin reinstated with a Neutral at Goldman Sachs
2M ago
BMRN
BioMarin price target raised to $116 from $104 at Canaccord
PremiumThe FlyBioMarin price target raised to $116 from $104 at Canaccord
2M ago
BMRN
BioMarin price target lowered to $119 from $120 at Morgan Stanley
Premium
The Fly
BioMarin price target lowered to $119 from $120 at Morgan Stanley
2M ago
BMRN
BioMarin price target raised to $120 from $110 at Evercore ISI
Premium
The Fly
BioMarin price target raised to $120 from $110 at Evercore ISI
2M ago
BMRN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >